Ben-Tzvi Avraham — SEC Form 4 filings
SEC reporting owner CIK 1944721. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-06.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-24 to 2026-08-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | Director | 3 | — | — | 3 |
| TITAN PHARMACEUTICALS INC (TTNP) | Director | 1 | — | — | 3 |
| Indaptus Therapeutics, Inc. (INDP) | Director | 1 | — | — | 2 |
| MINIM, INC. (MINM) | Director | 2 | — | — | 2 |
| Cyclacel Pharmaceuticals, Inc. (CYCC) | Director | 1 | — | — | 1 |
| OPGEN INC (OPGN) | Director | 1 | — | — | 1 |
Form 4 filings — Ben-Tzvi Avraham
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-06 | 4/A | Quantum Cyber N.V. (QUCY) | Grant/award (A): 112,859 @ $0 | EDGAR |
| 2026-08-05 | 4 | Quantum Cyber N.V. (QUCY) | Grant/award (A): 112,259 @ $0 | EDGAR |
| 2026-05-26 | 4 | Quantum Cyber N.V. (MYNZ) | Grant/award (A): 137,141 @ $0 | EDGAR |
| 2026-01-22 | 4 | Indaptus Therapeutics, Inc. (INDP) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | TITAN PHARMACEUTICALS INC (TTNP) | Disposition to issuer (D): 3,313 · Disposition to issuer (D): 1,250 (derivative) · Disposition to issuer (D): 5,000 (derivative) | EDGAR |
| 2025-02-28 | 4 | Cyclacel Pharmaceuticals, Inc. (CYCC) | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | MINIM, INC. (MINM) | Grant/award (A): 159,364 | EDGAR |
| 2024-04-15 | 4 | OPGEN INC (OPGN) | Grant/award (A): 100,000 | EDGAR |
| 2024-01-24 | 4 | MINIM, INC. (MINM) | Grant/award (A): 25,000 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1944721 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →